Cargando…

Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis

Glutathione (GSH) is an antioxidant in human cells that is utilized to prevent damage occurred by reactive oxygen species, free radicals, peroxides, lipid peroxides, and heavy metals. Due to its immunological role in tuberculosis (TB), GSH is hypothesized to play an important part in the immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abnousian, Arbi, Vasquez, Joshua, Sasaninia, Kayvan, Kelley, Melissa, Venketaraman, Vishwanath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216386/ https://www.ncbi.nlm.nih.gov/pubmed/37239011 http://dx.doi.org/10.3390/biomedicines11051340

Ejemplares similares

Additive Effects of Cyclic Peptide [R4W4] When Added Alongside Azithromycin and Rifampicin against Mycobacterium avium Infection
por: Kelley, Melissa, et al.
Publicado: (2023)

Topical Absorption of Glutathione–Cyclodextrin Nanoparticle Complex in Healthy Human Subjects Improves Immune Response against Mycobacterium avium Infection
por: Sasaninia, Kayvan, et al.
Publicado: (2023)

Effects of Glutathione Diminishment on the Immune Responses against Mycobacterium tuberculosis Infection
por: Cao, Ruoqiong, et al.
Publicado: (2021)

Understanding the Relationship between Glutathione, TGF-β, and Vitamin D in Combating Mycobacterium tuberculosis Infections
por: Singh, Mohkam, et al.
Publicado: (2020)

The Effects of Oral Liposomal Glutathione and In Vitro Everolimus in Altering The Immune Responses Against Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes
por: To, Kimberly, et al.
Publicado: (2021)

Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs
por: Kachour, Nala, et al.
Publicado: (2022)

Pathogenicity of Type I Interferons in Mycobacterium tuberculosis
por: Mundra, Akaash, et al.
Publicado: (2023)

Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
por: Guerra, Carlos, et al.
Publicado: (2011)

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model
por: Beever, Abrianna, et al.
Publicado: (2022)

Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis
por: Cao, Ruoqiong, et al.
Publicado: (2018)

Effects of Everolimus in Modulating the Host Immune Responses against Mycobacterium tuberculosis Infection
por: Raien, Anmol, et al.
Publicado: (2023)

Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19
por: Yegiazaryan, Aram, et al.
Publicado: (2022)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis – A Close View of the Immune System
por: Venketaraman, Vishwanath
Publicado: (2015)

Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
por: Morris, Devin, et al.
Publicado: (2012)

Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione
por: Allen, Michael, et al.
Publicado: (2015)

Effector Mechanisms of Neutrophils within the Innate Immune System in Response to Mycobacterium tuberculosis Infection
por: Warren, Eric, et al.
Publicado: (2017)

Glutathione and growth inhibition of Mycobacterium tuberculosis in healthy and HIV infected subjects
por: Venketaraman, Vishwanath, et al.
Publicado: (2006)

Elucidating the Efficacy of the Bacille Calmette–Guérin Vaccination in Conjunction with First Line Antibiotics and Liposomal Glutathione
por: Abrahem, Rachel, et al.
Publicado: (2019)

Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione—An Approach to Combat Opportunistic Infections
por: Kenchappa, Vanaja, et al.
Publicado: (2022)

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
por: Poladian, Nicole, et al.
Publicado: (2023)

Mycobacterium tuberculosis
por: Venketaraman, Vishwanath, et al.
Publicado: (2015)

Immunologic Role of Innate Lymphoid Cells against Mycobacterial tuberculosis Infection
por: Narinyan, William, et al.
Publicado: (2022)

Liposomal Glutathione Supplementation Restores T(H)1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected Individuals
por: Ly, Judy, et al.
Publicado: (2015)

Glutathione Supplementation as an Adjunctive Therapy in COVID-19
por: Guloyan, Vika, et al.
Publicado: (2020)

SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
por: Rangchaikul, Patrida, et al.
Publicado: (2021)

A Role of Intracellular Toll-Like Receptors (3, 7, and 9) in Response to Mycobacterium tuberculosis and Co-Infection with HIV
por: Nguyen, Huy, et al.
Publicado: (2020)

Glutathione synthesis is compromised in erythrocytes from individuals with HIV
por: Morris, Devin, et al.
Publicado: (2014)

Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially Mycobacterium tuberculosis
por: Ferlita, Steve, et al.
Publicado: (2019)

An Elucidation of Neutrophil Functions against Mycobacterium tuberculosis Infection
por: Morris, Devin, et al.
Publicado: (2013)

Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
por: Guilford, Timothy, et al.
Publicado: (2010)

Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process
por: Saing, Tommy, et al.
Publicado: (2016)

The Role of Glutathione in Prevention of COVID-19 Immunothrombosis: A Review
por: Glassman, Ira, et al.
Publicado: (2023)

Neutrophils in Mycobacterium tuberculosis
por: Alcantara, Cheldon Ann, et al.
Publicado: (2023)

Potentials of Host-Directed Therapies in Tuberculosis Management
por: Dara, Yash, et al.
Publicado: (2019)

Review of Pediatric Tuberculosis in the Aftermath of COVID-19
por: Rangchaikul, Patrida, et al.
Publicado: (2022)

Effects of ReadiSorb L-GSH in Altering Granulomatous Responses against Mycobacterium tuberculosis Infection
por: Islamoglu, Hicret, et al.
Publicado: (2018)

Protective Efficacy of BCG Vaccine against Mycobacterium leprae and Non-Tuberculous Mycobacterial Infections
por: Orujyan, Davit, et al.
Publicado: (2022)

Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection
por: Cerni, Stephen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fd00sfptbdf9e1l4qq3cuca67a